ReviewFrontiers in veterinary science2026
The gut-liver axis in animal diseases: roles, mechanisms, and veterinary clinical applications.
Review in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The liver serves as the core organ for metabolism, detoxification, and immune regulation in animals. Its functional homeostasis directly determines the animal's health status and production performance. The gut-liver axis, as a critical inter-organ regulatory network connecting the intestine and the liver, plays a vital role in regulating immune responses, maintaining nutritional metabolism balance, and preventing pathogen invasion. The review systematically elucidates the central role of the gut-liver axis in regulating metabolic homeostasis and immune defense in animals. It comprehensively integrates the structural foundations, regulatory mechanisms, and pathological functions of this axis across ruminants, pigs and poultry. It focuses on disruptions to intestinal barrier integrity and dynamic alterations in the gut microbiota and its metabolites (such as short-chain fatty acids, bile acids, etc.). These alterations directly or indirectly influence hepatic metabolism, immunity, detoxification functions and systemic inflammation, thereby contributing to the pathogenesis of various liver and related metabolic disorders. It provides intervention strategies based on gut-liver axis regulation, such as dietary interventions, probiotics/prebiotics, and microbiota-directed modulation. It also explores the application of artificial intelligence (AI) and big data modeling in monitoring the gut-liver axis with the goal of developing early warning systems. By integrating multi-omics technologies to identify key regulatory factors specific to the gut-liver axis, this work extends beyond the conventional gut-centric, single-organ framework to encompass multi-organ synergistic interactions. This approach provides novel theoretical insights and technical support for the discovery of multi-target bioactive compounds and the advancement of precision disease prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.